Beranda › Kanker (semua jenis) › Hawaii › Honolulu
Uji klinis Kanker (semua jenis) di Honolulu, HI
13 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Honolulu (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea · 7 mi jauhnya
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- dan 1 lainnya
Connect for Cancer Prevention Study (Connect)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Kaiser Permanente Hawaii, Honolulu
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- Hawaii Pacific Neuroscience, Honolulu
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Menerima pesertaStudi observasional
- Univercity of Hawaii Cancer Center, Honolulu
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Kapiolani Medical Center for Women and Children, Honolulu
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- dan 10 lainnya
EXoPERT EMERALD Clinical Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Hawaii Cancer Center, Honolulu
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 2/3
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- Spark M. Matsunaga VA Medical Center, Honolulu
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
Menerima pesertaSukarelawan sehat diterima
- Univesity of Hawaii Cancer Center, Honolulu
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Hawaii Cancer Care, Honolulu
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Honolulu
- Obesitas13 studi
- Kanker Payudara12 studi
- Kelebihan Berat Badan11 studi
- Kanker Paru Non-Sel Kecil10 studi
- Kanker Paru8 studi
- Leukemia Mieloid Akut7 studi
- Diabetes Tipe 27 studi
- Kanker Ovarium7 studi
- Kanker Pankreas7 studi
- Neuroblastoma6 studi
- Kanker Prostat5 studi
- Limfoma Burkitt5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.